Efficacy of adjuvant dexmedetomidine in supraclavicular brachial plexus block for intractable complex regional pain syndrome: A case report with a 3‐year follow‐up. (9th October 2019)

• Record Type: Journal Article
• Authors: Kang, Se Hee; Sim, Woo Seog; Park, Hue Jung; Moon, Jeong Yeon; Seon, Heui Jin; Lee, Jin Young
• Is Part Of: Journal of clinical pharmacy and therapeutics. Volume 45:Number 2(2020)
• Page Start: 365
• Page End: 367
• Publication Date: 2019-10-09
• Subjects: brachial plexus block -- complex regional pain syndrome -- dexmedetomidine -- supraclavicular; Clinical pharmacology -- Periodicals; Chemotherapy -- Periodicals; 615
• DOI: 10.1111/jcpt.13063
• Languages: English
• ISSNs: 0269-4727

Abstract

Abstract: What is known and objective: Pain management for complex regional pain syndrome (CRPS) is challenging. When added to local anaesthetics, dexmedetomidine prolongs the duration of the block and improves analgesia. The effect of long‐term dexmedetomidine use in the brachial plexus block (BPB) for CRPS is unknown. Case description: Here, we describe a case of satisfactory pain relief after supraclavicular BPB with dexmedetomidine every 1‐3 months over 2 years (10 treatments), in a patient with severe upper extremity CRPS‐related pain. What is new and conclusion: Repeated, long‐term, perineural administration of dexmedetomidine with BPB may be suitable for alleviating refractory CRPS pain.